{
    "ticker": "LMBS",
    "name": "Lombard Medical, Inc.",
    "description": "Lombard Medical, Inc. is a medical technology company focused on the development of innovative solutions for the treatment of vascular diseases. Established in 2007 and headquartered in Oxford, England, Lombard Medical specializes in the design and commercialization of advanced endovascular devices, particularly those for the treatment of abdominal aortic aneurysms (AAA). The company is committed to enhancing patient outcomes through the introduction of cutting-edge medical devices that leverage proprietary technology. Lombard Medical's flagship product, the Aorfix stent graft, is designed to provide a unique solution for patients with challenging anatomies, offering improved flexibility and adaptability during the implantation process. With a strong emphasis on research and development, Lombard Medical collaborates with leading healthcare professionals to ensure clinical needs are met and to bring innovative products to market. The company\u2019s mission is to improve the quality of life for patients suffering from vascular diseases while maintaining a commitment to safety and efficacy in all their medical devices. As a pioneer in the field, Lombard Medical continues to expand its product portfolio and enhance its presence in the global medical device market.",
    "industry": [
        "Medical Devices",
        "Healthcare"
    ],
    "headquarters": "Oxford, England, UK",
    "founded": "2007",
    "website": "http://www.lombardmedical.com",
    "ceo": "Simon Hubbert",
    "social_media": {
        "twitter": "https://twitter.com/lombardmed",
        "linkedin": "https://www.linkedin.com/company/lombard-medical"
    },
    "investor_relations": "http://www.lombardmedical.com/investors",
    "key_executives": [
        {
            "name": "Simon Hubbert",
            "position": "CEO"
        },
        {
            "name": "Peter L. H. B. V. J. V. L. K. A. van der Waal",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Endovascular Devices",
            "products": [
                "Aorfix Stent Graft"
            ]
        }
    ],
    "seo": {
        "meta_title": "Lombard Medical, Inc. | Innovative Solutions for Vascular Diseases",
        "meta_description": "Explore Lombard Medical, Inc., a leader in medical technology focused on vascular disease treatment. Discover our innovative endovascular devices and commitment to improving patient outcomes.",
        "keywords": [
            "Lombard Medical",
            "Vascular Disease",
            "Endovascular Devices",
            "Aortic Aneurysm",
            "Medical Technology"
        ]
    },
    "faq": [
        {
            "question": "What does Lombard Medical specialize in?",
            "answer": "Lombard Medical specializes in the development of innovative solutions for vascular diseases, particularly through endovascular devices."
        },
        {
            "question": "What is the Aorfix stent graft?",
            "answer": "The Aorfix stent graft is Lombard Medical's flagship product designed for the treatment of abdominal aortic aneurysms."
        },
        {
            "question": "Where is Lombard Medical headquartered?",
            "answer": "Lombard Medical is headquartered in Oxford, England, UK."
        },
        {
            "question": "Who is the CEO of Lombard Medical?",
            "answer": "Simon Hubbert is the CEO of Lombard Medical, Inc."
        },
        {
            "question": "When was Lombard Medical founded?",
            "answer": "Lombard Medical was founded in 2007."
        }
    ],
    "competitors": [
        "BDX",
        "ABT",
        "SYK"
    ],
    "related_stocks": [
        "MDT",
        "ISRG",
        "ZBH",
        "BSX"
    ]
}